Nile Therapeutics

San Francisco, United States Founded: 2023 • Age: 3 yrs
Developer of therapeutics for the treatment of cardiovascular diseases
Request Access

About Nile Therapeutics

Nile Therapeutics is a company based in San Francisco (United States) founded in 2023.. Nile Therapeutics has completed 1 acquisition, including Capricor Therapeutics. Nile Therapeutics operates in a competitive market with competitors including Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others.

  • Headquarter San Francisco, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Nile Therapeutics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Nile Therapeutics

Nile Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Capricor Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Regenerative medicine for cardiovascular disorders is developed using cell-based platforms.
2005
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Nile Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nile Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nile Therapeutics

Nile Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for cardiovascular and autoimmune diseases are developed.
domain founded_year HQ Location
Specialized drugs are developed for genetic heart diseases.
domain founded_year HQ Location
Developer of autologous cell therapies
domain founded_year HQ Location
Provider of tools for the analysis of RNA structures
domain founded_year HQ Location
Regenerative and gene therapeutics for heart failure are developed.
domain founded_year HQ Location
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nile Therapeutics

Nile Therapeutics to Acquire Capricor
Genengnews12 years ago

Frequently Asked Questions about Nile Therapeutics

When was Nile Therapeutics founded?

Nile Therapeutics was founded in 2023.

Where is Nile Therapeutics located?

Nile Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

What does Nile Therapeutics do?

Developer of therapeutics for the treatment of cardiovascular diseases. The companys products include CD-NP, a novel chimeric peptide for the treatment of heart failure and 2NTX-99, a small molecule, anti-atherothrombotic agent with nitric oxide (NO) donating properties.

Who are the top competitors of Nile Therapeutics?

Nile Therapeutics's top competitors include Tenaya Therapeutics, Cellino and MyoKardia.

How many acquisitions has Nile Therapeutics made?

Nile Therapeutics has made 1 acquisition, including Capricor Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available